A Case of Lymphangioma Treated by OK-432 (Picibanil(R)) Sclerotherapy.
- Author:
Bo Suk KIM
1
;
Tai Hyok WON
;
Phil Seung SEO
;
Seok Don PARK
Author Information
1. Department of Dermatology, Wonkwang University School of Medicine, Iksan, Korea. sdpark@wonkwang.ac.kr
- Publication Type:Case Report
- Keywords:
Lymphangioma;
OK-432
- MeSH:
Cryotherapy;
Endothelial Cells;
Humans;
Injections, Intralesional;
Laser Therapy;
Lymphangioma;
Lymphatic Vessels;
Mucous Membrane;
Picibanil;
Sclerosing Solutions;
Sclerotherapy
- From:Korean Journal of Dermatology
2008;46(10):1398-1401
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Lymphangioma is an uncommon, benign hyperproliferation of the lymphatic vessels, and this consists of dilated lymphatic channels lined by a normal, single layer of endothelial cells. Various methods have been tried for the treatment of lymphangioma, including cryotherapy, electrocauterization, surgical excision, laser therapy, radiotherapy and itralesional injection of sclerosing agents. Yet these methods have shown low success rates and various side effects. It has recently been reported that intralesional injection of OK-432 is a safe and effective alternative therapy for lymphangioma, and especially for macrocystic lesion. In this report, we describe a patient with lymphangioma on the upper labial mucosa and this patient was successfully treated with intralesional injection of OK-432 without any serious complications. To the best of our knowledge, this is the first such case reported on in the Korean dermatological literature.
